EASD 2020: Once-Weekly Basal Insulin Icodec Provides Comparable Efficacy and Safety to Once-Daily Insulin Glargine U100 in Insulin-Naïve Patients with Type 2 Diabetes Inadequately Controlled by OAD
Credit: Inna Luzan
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more